Outcomes for schizophrenia patients with clozapine treatment: how good does it get?
about
Clozapine for psychotic disorders in adults with intellectual disabilitiesClozapine for psychotic disorders in adults with intellectual disabilitiesIvabradine, a novel treatment for clozapine-induced sinus tachycardia: a case series.The Porirua Protocol in the Treatment of Clozapine-Induced Gastrointestinal Hypomotility and Constipation: A Pre- and Post-Treatment Study.Response trajectories to clozapine in a secondary analysis of pivotal trials support using treatment response to subtype schizophreniaClozapine-induced stuttering: an estimate of prevalence in the west of IrelandSubtyping Schizophrenia by Treatment Response: Antipsychotic Development and the Central Role of Positive Symptoms.Clozapine-induced hypersalivation: an estimate of prevalence, severity and impact on quality of lifePrescribing pattern of clozapine and other antipsychotics for patients with first-episode psychosis: a cross-sectional survey of early intervention teams.Is rational antipsychotic polytherapy feasible? A selective review.Clozapine for the treatment of schizophrenia.Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses.Reason for clozapine cessation.Reasons for discontinuing clozapine: A cohort study of patients commencing treatment.Current status of clozapine in the United States.Augmentation of clozapine with another pharmacological agent: treatment for refractory schizophrenia in the 'real world'.Pathway to clozapine use: a comparison between a patient cohort from New Zealand and a cohort from the United Kingdom.
P2860
Q24187048-D32EFC37-7BDF-421D-A552-CB0EC2C5FE37Q24202342-5C9E929B-337F-4589-BC37-C67A076D2E0AQ33937346-BD7DBE3F-080B-443B-9163-56654F762C65Q34544343-FCCA8E8C-47CA-4F06-AB8C-33D5E9B3DDD2Q35566098-CAFD6930-400C-4C8F-9AE1-1E3980C2636AQ35948871-4D8E89C0-1BBB-45A3-B11E-F1C653528FF4Q36371727-F1475DF6-2829-44AB-B6A2-481E5C4047C1Q37011466-7F6D452F-1A49-47FB-87D7-03D1E597EE75Q37705255-6F4639DA-3E1F-4A66-B929-16DADB715FB7Q37993473-729A5C5E-2F6D-4FC1-9989-1CD819756455Q38026886-4428715C-0FDB-44E8-8790-F28EBF2CC8A6Q38948958-B2C4401E-1AA7-46B1-94C6-492C49CB27D3Q39694991-69B61560-CE5D-4F97-B9C9-D9BFCBDBA891Q39745540-5B22745F-582E-46BF-BE1C-ED707DE5311FQ42946206-33552CD4-94EE-498A-87C5-CCE1B35644F8Q48001560-992C9AC0-5371-4F67-BC0B-26F1DCBECD0EQ50134375-9947CBA5-62EB-43E8-9247-E88DEC14188E
P2860
Outcomes for schizophrenia patients with clozapine treatment: how good does it get?
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Outcomes for schizophrenia patients with clozapine treatment: how good does it get?
@en
Outcomes for schizophrenia patients with clozapine treatment: how good does it get?
@nl
type
label
Outcomes for schizophrenia patients with clozapine treatment: how good does it get?
@en
Outcomes for schizophrenia patients with clozapine treatment: how good does it get?
@nl
prefLabel
Outcomes for schizophrenia patients with clozapine treatment: how good does it get?
@en
Outcomes for schizophrenia patients with clozapine treatment: how good does it get?
@nl
P2860
P356
P1476
Outcomes for schizophrenia patients with clozapine treatment: how good does it get?
@en
P2093
G Robinson
V Humberstone
P2860
P304
P356
10.1177/0269881108093588
P407
P577
2008-07-17T00:00:00Z